Mrv1718006241812242D 19 20 0 0 0 0 999 V2000型-0.7722 -0.3023 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.1847 0.9671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4396 0.1825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3597 0.9671 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.1047 0.1825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0856 -1.1273 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0 -1.7367 1.5802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2466 0.0110 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.5437 1.4087 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.7722 -1.1273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.7987 0.6240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3711 -1.5398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6566 -1.1273 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.4818 2.3649 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.0577 -1.5398 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.0577 -2.3649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7987 -1.5332 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.0830 -0.3006 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.3017 -1.9208 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3 1 1 0 0 0 0 5 1 1 0 0 0 0 10 1 1 0 0 0 0 3 2 2 0 0 0 0 7 2 1 0 0 0 0 4 2 1 0 0 0 0 8 3 1 0 0 0 0 5 4 2 0 0 0 0 12 6 1 0 0 0 0 14 7 1 0 0 0 0 9 8 7 2 0 0 0 0 11 2 0 0 0 0 11 9 1 0 0 0 0 15 10 1 0 0 0 0 13 12 1 0 0 0 0 15 13 1 0 0 0 0 15 16 1 6 0 0 0 6 17 1 0 0 0 0 6 2 0 0 0 0 6 19 18 1 0 0 0 0 M >结束
DB14126 >
drugbank >
C [C@H] (CN1C = NC2 = C1N = CN = C2N) (OCP (O) (O) = O >
InChI = 1 s / C9H14N5O4P c1-6 (18-5-19 (15、16) 17) 2-14-4-13-7-8 (10) 2-14-4-13-7-8 (7) 14 / h3-4, 6 h, 2、5 H2、h3, (H2, 10, 11, 12) (H2、15、16、17) / t6 - m1 / s1 >
SGOIRFVFHAKUTI-ZCFIWIBFSA-N >
C9H14N5O4P >
287.2123 >
287.078340473 >
8 >
33 >
25.540197161187024 >
1 >
3 >
0 >
0 >
({[(2 r) 1 - (6-amino-9H-purin-9-yl) propan-2-yl]氧}甲基)膦酸>
-1.51 >
-3.4393994481442403 >
-2.19 >
0 >
2 >
1 >
7.905167029353834 >
1.3503658045649996 >
3.7449691065560664 >
136.38 >
67.535 >
5 >
1 >
1.87 e + 00 g / l >
替诺福韦>
0 >
DB14126 >
实验;临床实验的>
替诺福韦>
(R) -PMPA;无水替诺福韦;替诺福韦;泰诺福韦(安);泰诺福韦(无水);替诺福韦无水>
替诺福韦水合物$ $ $ $